Influence of selective bowel decontamination on the organisms recovered during bacteremia in neutropenic patients

Infection Control and Hospital Epidemiology

Volumn 25, Issue 8, 2004, Pages 685-689

  Daxboeck, Florian ^a,d   Rabitsch, Werner ^b   Blacky, Alexander ^a   Stadler, Maria ^a   Kyrle, Paul A ^c   Hirschl, Alexander M ^d   Koller, Walter ^a  

^a Division of Hospital Hygiene   (Austria)

^b Department of Medical Oncology   (Turkey)

^c Division of Hematology   (United States)

^d MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; BACITRACIN; CHLORHEXAMIDE; NEOMYCIN; NYSTATIN; PAROMOMYCIN; POVIDONE IODINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANAEROBIC BACTERIUM; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BLOOD CULTURE; BONE MARROW TRANSPLANTATION; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISINFECTION; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; FUNGUS; HEMATOLOGIC DISEASE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; RETROSPECTIVE STUDY; SELECTIVE BOWEL DECONTAMINATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TEACHING HOSPITAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUSTRIA; BACTEREMIA; BONE MARROW TRANSPLANTATION; DECONTAMINATION; FEMALE; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; INTESTINES; MALE; MIDDLE AGED; NEUTROPENIA; RETROSPECTIVE STUDIES;

EID: 4143074658     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502463     Document Type: Article

References (12)

1. Klastersky J. Science and pragmatism in the treatment and prevention of neutropenic infection. J Antimicrob Chemother 1998;41(suppl D):13-24.
2. Collin B, Leather HL, Wingard JR, Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin Infect Dis 2001;33:947-953.
3. Brook I, Frazier EH. Infections caused by Propionibacterium species. Rev Infect Dis 1991;13:819-822.
4. Wisplinghoff H, Seifert H, Wenzel RP, Edmond MB. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin Infect Dis 2003;36:1103-1110.
5. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999;29:239-244.
6. Gonzalez-Barca E, Fernandez-Sevilla A, Carratala J, Granena A, Gudiol F. Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution. Eur J Clin Microbiol Infect Dis 1996;15:291-296.
7. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R. Trends and sources of nosocomial fungaemia. Mycoses 1994;37:187-190.
8. Damaso D, Moreno-Lopez M, Martinez-Beltran J, Garcia-Iglesias MC. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics. J Infect Dis 1976;134(suppl):S390-S394.
9. Murphy ME, Sepkowitz KA, Armstrong D. Prevention of infections in patients with hematologic malignancy. In: Wiernik PH, Canellos GP, Dutcher JP, Kyle RA, eds. Neoplastic Diseases of the Blood, ed. 3. New York: Churchill Livingstone; 1995:1007-1025.
10. Koplan JP, Hughes JM, Jaffe HW, et al. Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. MMWR 2000;49(RR-10):1-128.
11. Kirkpatrick BD, Harrington SM, Smith D, et al. Outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. Clin Infect Dis 1999;29:1268-1273.
12. Garrouste-Orgeas M, Chevret S, Mainardi JL, Timsit JF, Misset B, Carlet J. A one-year prospective study of nosocomial bacteraemia in ICU and non-ICU patients and its impact on patient outcome. J Hosp Infect 2000;44:206-213.